ChiCTR2600126362 版本V1.0 版本创建时间2026/06/08 14:42:50 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600126362 

最近更新日期:

Date of Last Refreshed on:

2026-06-08 14:42:41 

注册时间:

Date of Registration:

2026-06-08 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

老年髋部骨折患者术后心肌损伤风险预测模型的构建与验证:一项多中心回顾性队列研究

Public title:

Development and Validation of a Risk Prediction Model for Postoperative Myocardial Injury in Older Patients With Hip Fracture: A Multicenter Retrospective Cohort Study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

老年髋部骨折患者术后心肌损伤风险预测模型的构建与验证:一项多中心回顾性队列研究

Scientific title:

Development and Validation of a Risk Prediction Model for Postoperative Myocardial Injury in Older Patients With Hip Fracture: A Multicenter Retrospective Cohort Study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张子航 

研究负责人:

华震 

Applicant:

Zihang Zhang 

Study leader:

Zhen Hua 

申请注册联系人电话:

Applicant telephone:

+86 186 2281 4891

研究负责人电话:

Study leader's
telephone:

+86 133 1139 8620

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1610122505@pku.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

hua1013@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市东城区东单大华路一号

研究负责人通讯地址:

北京市东城区大华路1号

Applicant address:

1 Dahua Road, Dongcheng District, Beijing, China

Study leader's address:

1 Dahua Road, Dongcheng District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京协和医学院;北京医院

Applicant's institution:

Peking Union Medical College; Beijing Hospital

研究负责人所在单位:

北京医院

Affiliation of the Leader:

Beijing Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025BJYYEC-KY357-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京医院伦理委员会

Name of the ethic committee:

Beijing Hospital Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2025-12-01 00:00:00

伦理委员会联系人:

侯文静

Contact Name of the ethic committee:

Wenjing Hou

伦理委员会联系地址:

北京市东城区东单大华路 1 号

Contact Address of the ethic committee:

1 Dahua Road, Dongcheng District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 8513 8105

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京医院

Primary sponsor:

Beijing Hospital

研究实施负责(组长)单位地址:

北京市东城区大华路1号

Primary sponsor's address:

1 Dahua Road, Dongcheng District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京医院

具体地址:

北京市东城区东单大华路1号

Institution
hospital:

Beijing Hospital

Address:

1 Dahua Road, Dongcheng District, Beijing, China

经费或物资来源:

Source(s) of funding:

none

研究疾病:

老年髋部骨折  

Target disease:

hip fracture in elderly patients

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

基于可获得的围手术期变量,开发一个用于预测老年髋部骨折患者术后心肌损伤风险的临床预测模型,并利用多中心数据对其进行内部及外部验证。最终成果将转化为直观的列线图评分工具,便于临床床旁快速应用。  

Objectives of Study:

Based on readily available perioperative variables, we aimed to develop a clinical prediction model for postoperative myocardial injury in older patients with hip fracture and to perform internal and external validation using multicenter data. The final model will be translated into an intuitive nomogram-based scoring tool to facilitate rapid bedside clinical application.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1: 年龄≥65岁; 2: 因非病理性单侧髋部骨折并进行手术治疗; 3: 患者术后住院期间至少检测过一次肌钙蛋白; 4: 完整诊疗过程发生在上述时间范围内

Inclusion criteria

1. Age ≥65 years; 2. Underwent surgical treatment for a non-pathological unilateral hip fracture; 3. At least one postoperative troponin measurement during hospitalization; 4. The entire episode of care occurred within the specified study period.

排除标准:

1: 合并其他部位骨折; 2: 病理性骨折; 3: 保守治疗后出院者; 4: 麻醉记录缺失,无法明确麻醉方式; 5: 术后住院时间少于24小时或无法获得术后肌钙蛋白检测结果; 6: 围术期合并脓毒症

Exclusion criteria:

1. Concomitant fractures at other anatomical sites; 2. Pathological fracture; 3. Discharged after receiving conservative (nonoperative) treatment; 4. Missing anesthesia records precluding determination of the anesthetic technique; 5. Postoperative hospital stay of less than 24 hours or unavailable postoperative troponin measurements; 6. Perioperative sepsis.

研究实施时间:

Study execute time:

From 2025-12-01 00:00:00 To 2026-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-10 00:00:00 To 2026-06-30 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

2000

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京医院 

单位级别:

三甲 

Institution
hospital:

Beijing Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第一医院  

单位级别:

三甲 

Institution
hospital:

Peking University First Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东 

市(区县):

烟台 

Country:

China

Province:

Shandong

City:

Yantai

单位(医院):

烟台山医院 

单位级别:

三甲 

Institution
hospital:

Yantaishan Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

心肌损伤

指标类型:

主要指标

Outcome:

myocardial injury

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

论文发表后半年内,国家人口健康科学数据中心,https://www.ncmi.cn/index.html

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Within six months after the paper is published,National Population Health Science Data Center, https://www.ncmi.cn/index.html

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-06-08 14:42:41